United States Army Medical Research Institute of Chemical Defense
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:research_institute
|
| gptkbp:abbreviation |
gptkb:USAMRICD
|
| gptkbp:affiliation |
gptkb:United_States_Army
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:established |
1956
|
| gptkbp:focus |
gptkb:pharmacy
toxicology medical chemical defense treatment of chemical warfare agent exposure |
| https://www.w3.org/2000/01/rdf-schema#label |
United States Army Medical Research Institute of Chemical Defense
|
| gptkbp:location |
gptkb:Aberdeen_Proving_Ground
|
| gptkbp:mission |
develop medical countermeasures against chemical threats
|
| gptkbp:notableWork |
development of nerve agent antidotes
training in medical management of chemical casualties |
| gptkbp:parentOrganization |
gptkb:United_States_Army_Medical_Research_and_Development_Command
|
| gptkbp:researchArea |
medical countermeasures
chemical defense |
| gptkbp:state |
gptkb:Maryland
|
| gptkbp:type |
military medical research institute
|
| gptkbp:website |
https://usamricd.health.mil/
|
| gptkbp:bfsParent |
gptkb:USAMRICD
|
| gptkbp:bfsLayer |
8
|